Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neill

Showing results (51-60 of 268) with videos related to

Pageof 27
Sort By:
The Journal of Experimental Medicine|January 1, 1988
The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophagesM A Neill, S J Klebanoff
The American Journal of Cardiology|June 15, 1994
Asplenia syndrome--risk factors for early unfavorable outcomeC K Phoon, C A Neill
Gastroenterology Clinics of North America|October 6, 2001
Escherichia coli O157:H7P I Tarr, M A Neill
Critical Care (London, England)|February 29, 2008
Clostridium difficile: the increasingly difficult pathogenAurora Pop-Vicas, Marguerite A Neill
Texas Heart Institute Journal|January 1, 1994
Tetralogy of Fallot. The first 300 yearsC A Neill, E B Clark
Cardiology in the Young|May 14, 1999
The Paediatric Cardiology Hall of Fame: Helen Brooke Taussig MD. May 24, 1898 to May 21, 1986C A Neill, E B Clark
Vision Research|January 1, 1992
Effects of flicker modulation depth on the detection of changes in target locationR A Neill, C J Woodruff
Medical Laboratory Sciences|April 1, 1987
Generation of cytotoxic T cells to cytomegalovirus in patients with cervical intraepithelial neoplasiaW A Neill, E P Miller
The Journal of Infectious Diseases|November 1, 1996
Perspective: the problem of non-O157:H7 shiga toxin (Verocytotoxin)-producing Escherichia coliP I Tarr, M A Neill
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1982
Metabolic studies in the cat with atracurium: a neuromuscular blocking agent designed for non-enzymic inactivation at physiological pHE A Neill, D J Chapple
Pageof 27

Showing results (51-60 of 268) with videos related to

Sort By:
Pageof 27
The Journal of Experimental Medicine|January 1, 1988
The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophagesM A Neill, S J Klebanoff
The American Journal of Cardiology|June 15, 1994
Asplenia syndrome--risk factors for early unfavorable outcomeC K Phoon, C A Neill
Gastroenterology Clinics of North America|October 6, 2001
Escherichia coli O157:H7P I Tarr, M A Neill
Critical Care (London, England)|February 29, 2008
Clostridium difficile: the increasingly difficult pathogenAurora Pop-Vicas, Marguerite A Neill
Texas Heart Institute Journal|January 1, 1994
Tetralogy of Fallot. The first 300 yearsC A Neill, E B Clark
Cardiology in the Young|May 14, 1999
The Paediatric Cardiology Hall of Fame: Helen Brooke Taussig MD. May 24, 1898 to May 21, 1986C A Neill, E B Clark
Vision Research|January 1, 1992
Effects of flicker modulation depth on the detection of changes in target locationR A Neill, C J Woodruff
Medical Laboratory Sciences|April 1, 1987
Generation of cytotoxic T cells to cytomegalovirus in patients with cervical intraepithelial neoplasiaW A Neill, E P Miller
The Journal of Infectious Diseases|November 1, 1996
Perspective: the problem of non-O157:H7 shiga toxin (Verocytotoxin)-producing Escherichia coliP I Tarr, M A Neill
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1982
Metabolic studies in the cat with atracurium: a neuromuscular blocking agent designed for non-enzymic inactivation at physiological pHE A Neill, D J Chapple
Pageof 27